Genomenon builds an AI-driven genomic knowledge platform that connects current research with patient DNA to accelerate clinical decision-making and pharmaceutical drug discovery. Its core product is a genomic data hub that curates and links the evolving body of genomic literature to support diagnoses and precision-medicine development. The platform is designed for genetic testing labs, hospitals, pharmaceutical, and biopharma companies. Genomenon leverages AI to organize the world’s genomic knowledge and put it at the fingertips of doctors and clinicians. Following a March 2022 fundraise, the company plans to expand commercial operations and further develop its genomic data hub to better serve clinical and research customers. The company’s stated mission is to save and improve lives by making genomic information actionable.

Total raised

$20M

Funding rounds

1

Latest round

Series B

Latest activity

Mar 2022